Loredana Battipaglia

CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window

Gino Villetti, Chiara Carnini, Loredana Battipaglia et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 49 citations · Full text

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

G. Villetti, Francesco Saverio Pastore, M. Bergamaschi et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 28 citations

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases

Laura Carzaniga, Gabriele Amari, Andrea Rizzi et al. · Journal of Medicinal Chemistry · 2017 · 21 citations · Full text

Pharmaceutical Science, Inflammatory Lung Disease, Phosphodiesterase 4 +18

Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives

Eleonora Ghidini, Maurizio Delcanale, Renato De Fanti et al. · Bioorganic & Medicinal Chemistry · 2006 · 19 citations

Medicinal Chemistry, 2-Aminoacetamide Derivatives, Medicine +3